View Older Stories View More Recent Stories

May 29, 2025 10:59AM Morgan Stanley Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
May 29, 2025 07:29AM TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN'
May 28, 2025 03:00PM Biohaven Pharma (BHVN) Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day
May 28, 2025 07:32AM Biohaven Pharma (BHVN) Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates
May 13, 2025 09:43AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $54 at RBC Capital
May 12, 2025 04:57PM Biohaven Pharma (BHVN) Misses Q1 EPS by 47c
Apr 28, 2025 07:31AM Biohaven Pharma (BHVN) Announces Investment up to $600 Million by Oberland Capital
Apr 28, 2025 05:47AM Biohaven Pharma (BHVN) call put ratio 2 call to 1 put with a focus on May calls
Apr 25, 2025 10:09AM Biohaven Pharma (BHVN) Halted on Volatility Down 18%
Apr 25, 2025 10:08AM Biohaven Pharma (BHVN) Withdraws Application For Troriluzole In EU
Apr 21, 2025 05:19AM Increasing unusual call option volume: XND HTZ UMC BHVN UMC AMCR HDB AEVA NICE FTI
Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Mar 26, 2025 07:02AM Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 7, 2025 06:42AM Piper Sandler on Biohaven Pharmaceutical Holding (BHVN): 'Industry-Leading Pipeline Continues to Mature'
Mar 6, 2025 10:16AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Morgan Stanley
Mar 5, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Mar 5, 2025 05:21AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Jefferies
Mar 4, 2025 10:39AM TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'BHV-1300 Is Crushing Its Target'
Mar 4, 2025 10:26AM RBC on Biohaven Pharmaceutical Holding (BHVN): 'Stock Reaction Overdone On Bipolar Miss'
Mar 4, 2025 06:52AM Bernstein: 'Still like Biohaven Pharmaceutical Holding (BHVN) Stock but No Longer a Top Pick'; PT Lowered
Mar 3, 2025 04:25PM Biohaven Pharma (BHVN) Misses Q4 EPS by 11c
Mar 3, 2025 12:35PM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
Mar 3, 2025 07:31AM Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
Feb 11, 2025 07:31AM Biohaven Pharma (BHVN) Announces FDA Acceptance and Priority Review of Troriluzole NDA
Feb 11, 2025 04:15AM Deutsche Bank Starts Biohaven Pharmaceutical Holding (BHVN) at Buy
Jan 29, 2025 09:12AM Cantor Fitzgerald provides update on Biotechnology stocks
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 8, 2025 06:00PM Bernstein's top two SMID biotech picks for 2025
Dec 17, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Dec 17, 2024 06:47AM Bernstein on Biohaven Pharmaceutical Holding (BHVN): 'BHVN Remains One of Our Top Picks'
Dec 16, 2024 07:30AM Biohaven Pharma (BHVN) Reports Positive Phase 1 Degrader Data
Dec 6, 2024 07:30AM Biohaven Pharma (BHVN) Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates
Dec 4, 2024 08:59AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $61 at RBC Capital
Dec 2, 2024 04:00PM Here are the key catalysts for 3 US biotech stocks into year end
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Nov 25, 2024 11:24AM Baird Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Nov 25, 2024 09:46AM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
Nov 25, 2024 07:43AM Biohaven Pharma (BHVN) Falls 13% Following Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
Nov 25, 2024 07:32AM Biohaven Pharma (BHVN) Provides Update on Taldefgrobep Alfa Development Program
Nov 13, 2024 11:18AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $75 at TD Cowen
Nov 13, 2024 06:44AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $66 at RBC Capital
Nov 12, 2024 04:09PM Biohaven Pharma (BHVN) Misses Q3 EPS by 4c
Oct 15, 2024 06:12AM BofA Securities Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 04:08PM Leerink Partners Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 03:41PM BTIG Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 10:20AM Baird Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 06:16AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $63 at BofA Securities
Oct 3, 2024 06:01AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $68 at JPMorgan
View More Recent Stories View Older Stories